drugset / Trial / NCT05552495
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-386 in healthy volunteers under fasting conditions.
Timeline
- Start
- 2022-09-23
- Primary completion
- 2022-11-27
- Completion
- 2022-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-386 | Unknown | — | — |
| Subject | D013 | Unknown | — | — |
| Subject | D326 | Unknown | — | — |
| Subject | D337 | Unknown | — | — |